Deal to add navenibart, a late-stage and long-acting plasma kallikrein inhibitor, in Phase 3 clinical development, to BioCryst’s HAE portfolio –– Solidifies double digit growth trajectory for HAE ...
Robin Crauthers of McCarter & English LLP, and Rishi Chhatwal and Hilary Quatinetz of Alvarez & Marsal discuss best practices ...
FB Financial Corporation (the "Company") (NYSE: FBK), parent company of FirstBank, reported net income of $23.4 million, or $0.43 per diluted common share, for the third quarter of 2025, compared to ...
Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the “M&A Class Action Firm”), has recovered millions of dollars for shareholders ...
The court case stems from a months-long HR investigation into PSC President Brad Molnar, and a subsequent letter from the PSC ...
Deep Fission is a fledgling startup that says it can help tech companies meet the "explosive demand" for more energy to power ...
Explore Xcel Energy Inc.'s 6.25% Junior Subordinated Notes: strong fundamentals but limited upside. Click for more on XEL and ...
Deep Fission is a fledgling startup that says it can help tech companies meet the 'explosive demand' for more energy to power ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback